COMMUNIQUÉS West-GlobeNewswire

Cantabio Pharmaceuticals to Present Latest Positive In Vivo Results From its DJ-1 Targeting Small Molecule Drug Development Program for Parkinson’s Disease at the Milner Therapeutics Symposium at the University of Cambridge, UK
01/10/2018
SAN FRANCISCO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals Inc. (OTCQB: CTBO), a biopharmaceutical company developing novel disease modifying therapies for Alzheimer's (AD), Parkinson's (PD) and other [...]
Nova Leap Health Corp. Completes Purchase of Third Massachusetts Home Care Business
01/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Oct. 01, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]
Cleveland Area Hospital Selects Cerner for Improved Rural Patient Care
01/10/2018
CLEVELAND, Okla., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Cleveland Area Hospital has selected Cerner, a global leader in health care technology, to implement a new integrated electronic health record (EHR) and revenue cycle [...]
Editas Medicine Grows Scientific Leadership with Two New Appointments
01/10/2018
CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that Richard A. Morgan, Ph.D., a leading expert in gene therapy and oncology, [...]
Advantis Corp Set to Debut Proprietary Sublingual Delivery System, Edible Orders Ramp Up Quickly
01/10/2018
NEWPORT BEACH, CA, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - ADVANTIS CORPORATION (OTC PINK: ADVT) provided additional details about its sublingual tabs today, and revealed a proprietary process for med [...]
Medibio Named Finalist for Prestigious Optus My Business Award
01/10/2018
The awards are the longest-standing business awards program in Australia, identifying and acknowledging the achievements of Australia’s best business operators MINNEAPOLIS, Minn. and SYDNEY, Australia, Oct. 01, 2018 ( [...]
Diversicare and Omega Enter Into a New Master Lease Agreement
01/10/2018
BRENTWOOD, Tenn., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced that pursuant to the binding agreement between [...]
Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
01/10/2018
CALGARY, Alberta, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today the publication of a scientific article in the [...]
Pressure BioSciences Inc. Discusses New Instrument Release, Entry into the Worldwide Food Science Area, and their Innovative Ultra Shear Technology Platform on Uptick Newswire’s Stock Day Podcast
01/10/2018
PHOENIX, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Pressure BioSciences Inc. (OTCQB: PBIO ) (the “Company”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform [...]
CO2 GRO Announces 74% Increased Commercial Cannabis Bud Value
01/10/2018
Results of Third Dissolved CO2 Foliar Spray Cannabis Trial Demonstrates Continued Dramatic Increases in Value TORONTO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Toronto based CO2 GRO Inc. (“ GROW ” or the “ Company ”) (TSX-V: [...]
Vilacto Bio Announces Launch of Carmen Electra by Vilact®
01/10/2018
COPENHAGEN, Denmark, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has launched its new skincare product, Carmen Electra by Vilact , based on the company’s LACTOACTIVE® compound. LACTOACTIVE® is the [...]
Innovate Biopharmaceuticals Announces Participation at the Ladenburg Thalmann 2018 Healthcare Conference
01/10/2018
RALEIGH, N.C., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and [...]
48North Joins Forces with Mother & Clone to License Sublingual Nanospray in Canada -- CFN Media
01/10/2018
SEATTLE, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Aurora Orders Big; Larger-Size Orders Surge
01/10/2018
CORONA, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- MedTainer Inc. (ACOL-OTC) announced today that Aurora Cannabis (OTCMARKETS:ACBFF,TSE:ACB) has placed its’ 7th order for thousands of MedTainers in anticipation of the [...]
Novo Nordisk A/S - Share repurchase programme
01/10/2018
Bagsværd, Denmark, 1 October 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Melinta Therapeutics and Menarini Group Enter Commercial Agreement for Vabomere™ (meropenem and vaborbactam), Orbactiv® (oritavancin) and Minocin® (minocycline) for Injection in 68 Countries
01/10/2018
- Total consideration of up to $265 million (including potential royalties) - - Expands on existing commercial and co-development agreement for Baxdela ® (delafloxacin) - NEW HAVEN, Conn. and FLORENCE, Italy, Oct. 01, [...]
BeiGene Presents Results on Anti-PD-1 Antibody Tislelizumab in Chinese Patients with Lung Cancers at the Annual Meeting of the Chinese Society of Clinical Oncology
21/09/2018
BEIJING, China, and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Molecular Templates, Inc. Announces Pricing of Public Offering of Common Stock
21/09/2018
AUSTIN, Texas, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of proprietary engineered toxin bodies [...]
CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
21/09/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]

Pages